Evidence map›Paper›PMID 29261004›Full record

ReviewVirulence2018

Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi.

Surbhi Verma, Viplendra P S Shakya, Alexander Idnurm

Open access · goldAbstract readReview
In one paragraph

Review in Virulence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cryptococcal nutrient acquisition and pathogenesis: dining on the host.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Exploration of novel mechanisms of azole resistance inAntimicrobial agents and chemotherapy · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Surbhi Vermaa Department of Biochemistry , University of Utah School of Medicine , Salt Lake City , Utah , USA.
Viplendra P S Shakyaa Department of Biochemistry , University of Utah School of Medicine , Salt Lake City , Utah , USA.
Alexander Idnurmb School of BioSciences , University of Melbourne , Parkville , VIC , Australia.
University of Utah · USUniversity of Melbourne · AU

Funding

Antifungal drug target prioritization using Cryptococcus neoformansR21AI094364 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI IDNURM, ALEXANDER · 2012 to 2013
$409k
NIAID NIH HHS R21 AI094364
6 · The paper itself

Abstract

Mitochondria are best known for their role in the production of ATP; however, recent research implicates other mitochondrial functions in the virulence of human pathogenic fungi. Inhibitors of mitochondrial succinate dehydrogenase or the electron transport chain are successfully used to combat plant pathogenic fungi, but similar inhibition of mitochondrial functions has not been pursued for applications in medical mycology. Advances in understanding mitochondrial function relevant to human pathogenic fungi are in four major directions: 1) the role of mitochondrial morphology in virulence, 2) mitochondrial genetics, with a focus on mitochondrial DNA recombination and mitochondrial inheritance 3) the role of mitochondria in drug resistance, and 4) the interaction of mitochondria with other organelles. Collectively, despite the similarities in mitochondrial functions between fungi and animals, this organelle is currently an under-explored potential target to treat medical mycoses. Future research could define and then exploit those mitochondrial components best suited as drug targets.

Indexed as

Energy MetabolismAntifungal AgentsFungiHumansMitochondriaMycosesVirulenceAntifungal AgentsAspergillus fumigatusazole antifungalCandidaCryptococcushemeironmitochondriapathogenicityrecombination

Identifiers

PMID29261004
PMCPMC5955198
OpenAlexW2780456459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.